Amet Medical secures over 200 million yuan in Series D financing

36Kr learned that on April 9, "Amit Medical" announced the completion of over 200 million yuan in Series D financing. This round of financing was led by Zhejiang Collaborative Life Science Fund, with follow-on investments from institutions such as Henan Key Intellectual Property Fund and Global Hedge Fund Management Co., Ltd. The funds will be used to accelerate the R & D of core products (including the commercially available carbon dioxide non-nephrotoxic contrast device and the in - development fully degradable stent), global market promotion, and international strategic layout.